Ivan Liakh1, Agata Janczy2, Alicja Pakiet3, Justyna Korczynska4, Monika Proczko-Stepaniak5, Lukasz Kaska5, Tomasz Sledzinski4, Adriana Mika6. 1. Department of Toxicology, Medical University of Gdansk, Gdansk, Poland. 2. Department of Clinical Nutrition, Medical University of Gdansk, Gdansk, Poland. 3. Department of Environmental Analysis, Faculty of Chemistry, University of Gdansk, Gdansk, Poland. 4. Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland. 5. Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland. 6. Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland. adrianamika@tlen.pl.
Abstract
BACKGROUND/ OBJECTIVES: Oxylipins are polyunsaturated fatty acid derivatives involved in the regulation of various processes, including chronic inflammation, insulin resistance and hepatic steatosis. They can be synthesized in various tissues, including adipose tissue. There is some evidence that obesity is associated with the deregulation of serum oxylipin levels. The aim of this study was to evaluate the effect of bariatric surgery (one-anastomosis gastric bypass) on the serum levels of selected oxylipins and their fatty acid precursors and to verify the hypothesis that their changes after surgery can contribute to the resolution of inflammation. Moreover, we compared the oxylipin levels (prostaglandin E2, 13-HODE, maresin 1 and resolvin E1), fatty acids and the expression of enzymes that synthesize oxylipins in adipose tissue of lean controls and subjects with severe obesity. SUBJECTS/ METHODS: The study included 50 patients with severe obesity that underwent bariatric surgery and 41 subjects in lean, control group. Fatty acid content was analyzed by GC-MS, oxylipin concentrations were measured with immunoenzymatic assay kits and real-time PCR analysis was used to assess mRNA levels in adipose tissue. RESULTS: Our results show increased expression of some enzymes that synthesize oxylipins in adipose tissue and alterations in the levels of oxylipins in both adipose tissue and serum of subjects with obesity. After bariatric surgery, the levels of anti-inflammatory oxylipins increased, whereas pro-inflammatory oxylipins decreased. CONCLUSIONS: In patients with obesity, the metabolism of oxylipins is deregulated in adipose tissue, and their concentrations in serum are altered. Bariatric surgery modulates the serum levels of pro- and anti-inflammatory oxylipins, which may contribute to the resolution of inflammation.
BACKGROUND/ OBJECTIVES: Oxylipins are polyunsaturated fatty acid derivatives involved in the regulation of various processes, including chronic inflammation, insulin resistance and hepatic steatosis. They can be synthesized in various tissues, including adipose tissue. There is some evidence that obesity is associated with the deregulation of serum oxylipin levels. The aim of this study was to evaluate the effect of bariatric surgery (one-anastomosis gastric bypass) on the serum levels of selected oxylipins and their fatty acid precursors and to verify the hypothesis that their changes after surgery can contribute to the resolution of inflammation. Moreover, we compared the oxylipin levels (prostaglandin E2, 13-HODE, maresin 1 and resolvin E1), fatty acids and the expression of enzymes that synthesize oxylipins in adipose tissue of lean controls and subjects with severe obesity. SUBJECTS/ METHODS: The study included 50 patients with severe obesity that underwent bariatric surgery and 41 subjects in lean, control group. Fatty acid content was analyzed by GC-MS, oxylipin concentrations were measured with immunoenzymatic assay kits and real-time PCR analysis was used to assess mRNA levels in adipose tissue. RESULTS: Our results show increased expression of some enzymes that synthesize oxylipins in adipose tissue and alterations in the levels of oxylipins in both adipose tissue and serum of subjects with obesity. After bariatric surgery, the levels of anti-inflammatory oxylipins increased, whereas pro-inflammatory oxylipins decreased. CONCLUSIONS: In patients with obesity, the metabolism of oxylipins is deregulated in adipose tissue, and their concentrations in serum are altered. Bariatric surgery modulates the serum levels of pro- and anti-inflammatory oxylipins, which may contribute to the resolution of inflammation.
Authors: Alison H Keenan; Theresa L Pedersen; Kristi Fillaus; Mark K Larson; Gregory C Shearer; John W Newman Journal: J Lipid Res Date: 2012-05-24 Impact factor: 5.922
Authors: Samantha D Pauls; Youjia Du; Luc Clair; Tanja Winter; Harold M Aukema; Carla G Taylor; Peter Zahradka Journal: Arterioscler Thromb Vasc Biol Date: 2020-12-31 Impact factor: 8.311
Authors: Leyre Martínez-Fernández; Laura M Laiglesia; Ana E Huerta; J Alfredo Martínez; María J Moreno-Aliaga Journal: Prostaglandins Other Lipid Mediat Date: 2015-07-26 Impact factor: 3.072
Authors: Alex S Yamashita; Thiago Belchior; Fábio S Lira; Nicolette C Bishop; Barbara Wessner; José C Rosa; William T Festuccia Journal: Mediators Inflamm Date: 2018-07-04 Impact factor: 4.711